Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

DoW Breast Cancer, Clinical Research Extension Award

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

N/A

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 20

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

View Agency Profile

Office AddressUSA

Contacts

eBRAP Help Desk

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.

Distinctive Features:

• The research team must include two or more breast cancer consumer advocates.

• This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

POSTED

DEADLINE

DoW Reconstructive Transplant, Investigator-Initiated Research AwardThe fiscal year 2026 Reconstructive Transplant Research Program Investigator-Initiated Research Award provides funding for studies aimed at improving reconstructive transplant research, patient care, and quality of life. This forecast, managed by the Defense Health Agency Contracting Activity for the Department of Defense, supports a broad scope of research ranging from basic and preclinical animal models to translational clinical research in human subjects. All proposed projects must align with the FY26 RTRP Focus Areas and demonstrate a strong scientific rationale supported by required preliminary or published data. To be eligible, projects must exhibit military-relevant utility by addressing the healthcare needs of Service Members, Veterans, their families, caregivers, or clinicians, as well as the general public. While collaboration with military researchers is encouraged, it is not mandatory. Applicants must provide a rigorous study design with a robust statistical plan to ensure reproducibility and translational feasibility. Notably, this award does not support clinical trials.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Scientific Peer Review and Grant Evaluation ServicesThe contract seeks qualified independent scientific reviewers to conduct peer evaluations of research proposals submitted to the Defense Health Agency under the Department of Defense's Congressional Directed Medical Research Programs. The review process must rigorously assess proposals based on five core criteria established by DoD/CDMRP standards: scientific significance, innovation, methodological approach, investigator qualifications, and the adequacy of the research environment. Reviewers are expected to deliver impartial, expert-level analyses that inform funding decisions and uphold the integrity of the military healthcare research portfolio. This engagement is structured as a subcontract under NAICS code 541690, with a response deadline of September 22, 2026, and is open to entities capable of supporting high-stakes, mission-critical scientific evaluation under federal oversight.

Other Scientific and Technical Consulting Services

POSTED

about 2 months ago

DEADLINE

in about 1 month

Regulatory and Reporting Compliance SupportThe contract supports the preparation and submission of regulatory documentation required for federal research compliance, with specific attention to foreign affiliation disclosures, biosketches, and current and pending support forms. It mandates strict adherence to NSPM-33 guidelines and CDMRP requirements, ensuring that all submitted materials meet the Department of Defense’s standards for transparency, accountability, and conflict-of-interest management. This work is critical for maintaining eligibility for federal funding and ensuring alignment with national security and ethical research protocols. This is a subcontract awarded under the NAICS code 541611 for scientific research and development services, with a response deadline of September 22, 2026, and a posting date of June 25, 2026. The contracting activity is managed by the Defense Health Agency Contracting Activity under the Department of Defense, though specific performance location and point of contact details are not provided. All work is expected to be performed in compliance with federal regulations governing research integrity and external funding disclosures, and the subcontractor must possess expertise in navigating complex regulatory environments tied to defense-funded biomedical and health research initiatives.

Administrative Management and General Management Consulting Services

POSTED

about 2 months ago

DEADLINE

in about 1 month

Scientific Data Management and FAIR Compliance SupportThe contract seeks support for scientific data management with a focus on achieving full compliance with FAIR principles—ensuring research outputs are Findable, Accessible, Interoperable, and Reusable. This includes comprehensive data curation, precise metadata tagging, and end-to-end repository management to enhance the quality, discoverability, and long-term utility of defense-related research data. The effort requires seamless integration with Department of Defense systems, particularly eBRAP, to synchronize data workflows and uphold institutional standards for documentation, access, and reporting. The work is structured as a subcontract under the Defense Health Agency Contracting Activity, classified under NAICS code 541690 for other scientific and technical consulting services. Proposals must be submitted by September 22, 2026, and performance is expected to support critical DoD research initiatives, with no geographic restrictions specified for the place of performance. The contract emphasizes technical rigor in data governance, alignment with federal data stewardship mandates, and the ability to operate within highly regulated defense environments to ensure compliance, security, and interoperability across systems.

Other Scientific and Technical Consulting Services

POSTED

about 2 months ago

DEADLINE

in about 1 month

Neurofibromatosis Research Execution – Hypothesis-Driven Laboratory StudiesThe contract seeks to advance understanding of neurofibromatosis through innovative, hypothesis-driven laboratory research aimed at addressing high-impact scientific questions with the potential to reshape current paradigms in disease mechanisms or therapeutic approaches. The work requires rigorous experimental design, comprehensive data collection and analysis, and clear reporting of findings, all focused on generating transformative insights that could lead to novel treatments or diagnostic strategies. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541715 for research and development in the physical, engineering, and life sciences. Proposals must be submitted by September 22, 2026, with the research expected to be conducted at the performer’s facility, though the specific location is not designated. The initiative prioritizes originality and scientific impact over incremental progress, demanding a strong theoretical foundation and the potential to significantly alter the landscape of neurofibromatosis research.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 2 months ago

DEADLINE

in about 1 month

Scientific Editing and Grant Writing SupportThe contract seeks qualified vendors to deliver professional editing, writing, and formatting services focused on technical reports, progress reviews, and scientific publications for the Defense Health Agency Contracting Activity. Services must meet high standards of clarity, accuracy, and compliance with federal and military documentation requirements, with an emphasis on technical and scientific content. The work is classified as a subcontract and falls under NAICS code 541618, which covers other scientific and technical consulting services. Respondents must submit proposals by the deadline of September 22, 2026, and the opportunity was posted on June 25, 2026. No specific location is designated for performance, and there is no set-aside designation, meaning all eligible entities may compete. The contract is managed under the Department of Defense and is accessible through the Grants.gov platform for full details and submission.

Other Management Consulting Services

POSTED

about 2 months ago

DEADLINE

in about 1 month

Data Management and Sharing Plan DevelopmentThe contract requires the development and implementation of a compliant Data Management and Sharing Plan in accordance with NIH and Department of Defense requirements, focusing on establishing robust metadata standards, selecting appropriate data repositories, and defining strict access controls to ensure data integrity and regulatory adherence. The successful offeror must align all activities with federal guidelines to facilitate transparent, secure, and reusable data sharing practices across research initiatives funded by these organizations. Work under this subcontract must be completed by the September 22, 2026, deadline and will be performed under the auspices of the Defense Health Agency Contracting Activity within the Department of Defense. The NAICS code 518210 indicates this involves data processing, hosting, and related services, emphasizing technical expertise in compliant data infrastructure. There is no set-aside designation, and while specific performance location details are not provided, the effort is expected to support broader DoD and NIH research objectives through standardized, scalable, and auditable data management practices.

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

about 2 months ago

DEADLINE

in about 1 month

Molecular and Genomic Laboratory TestingThe contract seeks a subcontractor to conduct advanced molecular and genomic testing on tissue samples from individuals with neurofibromatosis, specifically focusing on next-generation sequencing, RNA sequencing, and other related molecular profiling techniques. The work aims to generate detailed genetic and transcriptomic data to enhance understanding of the disease’s molecular mechanisms, with the expectation that results will support clinical or research initiatives tied to defense health programs. All testing must adhere to high standards of accuracy, reproducibility, and data integrity, with samples received from designated sources and processed under protocols that ensure traceability and quality control. The opportunity is posted under NAICS code 541380, indicating it is classified as other scientific and technical consulting services, and is issued by the Defense Health Agency Contracting Activity under the Department of Defense. Interested parties must submit proposals by the deadline of September 22, 2026, and the work is expected to be performed domestically though the exact location is not specified. The contract does not include set-aside provisions for small businesses or other designated categories, and there is no designated point of contact listed in the posting. Proposals should demonstrate technical expertise in genomic analysis, experience with clinical or research-grade tissue samples, and the capacity to deliver actionable data within stringent timelines.

Testing Laboratories and Services

POSTED

about 2 months ago

DEADLINE

in about 1 month

Clinical Trial Design and Biostatistical SupportThe contract seeks a subcontractor to provide comprehensive biostatistical consulting services in support of clinical and translational research initiatives, with a focus on study design, power analysis, randomization procedures, and the development of robust data analysis plans. The work is intended to ensure methodological rigor and statistical validity across defense-related health research projects, requiring expertise in applying statistical principles to real-world clinical trial scenarios. The contractor must be capable of tailoring statistical methodologies to the unique constraints and objectives of military and veteran health research environments. This opportunity is issued under the Defense Health Agency Contracting Activity, operating within the Department of Defense, and is classified under NAICS code 541611 for scientific research and development services. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026. Performance location details are not specified, indicating potential flexibility in execution, though the work must align with the Agency’s operational and research priorities. As a subcontract, this engagement is likely part of a larger research initiative, and proposers should be prepared to collaborate effectively with primary contractors and federal research teams to deliver timely, high-quality statistical support.

Administrative Management and General Management Consulting Services

POSTED

about 2 months ago

DEADLINE

in about 1 month

Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.

Research and Development in Biotechnology

POSTED

about 2 months ago

DEADLINE

in about 1 month

Foreign Affiliation and Conflict of Interest (COI) Disclosure ManagementThe contract focuses on supporting the identification, documentation, and timely disclosure of foreign affiliations and conflicts of interest among key personnel to ensure strict compliance with NSPM-33 and all applicable federal research security mandates. This effort is critical for safeguarding federally funded research integrity by mitigating risks associated with undue foreign influence and ensuring transparency in personnel relationships with foreign entities. The work requires thorough vetting of affiliations, accurate recordkeeping, and structured reporting processes aligned with government standards. The subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and is classified under NAICS code 541611, indicating it pertains to scientific research and development services. The opportunity was posted on June 25, 2026, with a response deadline set for September 22, 2026. The performance location is not specified, and no set-aside provisions or point of contact details are provided, but the scope demands specialized expertise in research compliance, institutional policy alignment, and federal security protocols for high-risk research environments.

Administrative Management and General Management Consulting Services

POSTED

about 2 months ago

DEADLINE

in about 1 month